These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 4780106)

  • 1. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 2. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of preparations of typhoid antigens obtained by ultrafiltration].
    Khokholev LS; Shapiro NI; Katalevskiĭ EE
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):81-4. PubMed ID: 7234247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of Vi antigen and toxicity in typhoid vaccines inactivated by acetone or by heat and phenol.
    Wong KH; Feeley JC; Pittman M; Forlines ME
    J Infect Dis; 1974 May; 129(5):501-6. PubMed ID: 4207306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic efficacy of typhoid alcoholic vaccine enriched with Vi-antigen in opisthorchiasis].
    Baranova NA; Peklo GN; Razmashkina AP
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Nov; 49(11):66-9. PubMed ID: 4645855
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO; Levine MM; Robbins JB
    Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Live enteric typhoid vaccine consisting of a Vi-negative double-dependent mutant of S. typhi and a Vi-positive strain of Citrobacter].
    Pershin BB; Shuster BIu; Maganet LS; Tolcheev IuD
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):35-40. PubMed ID: 60853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially].
    Khatuntseva NV; Mironova MV; Riapolova RG; Rybasova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.
    Chernokhvostova E; Luxemburg KI; Starshinova V; Andreeva N; German G
    Clin Exp Immunol; 1969 Apr; 4(4):407-21. PubMed ID: 4182404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of oral and subcutaneous immunization against typhoid-paratyphoid fever (author's transl)].
    Krasnoproshina LI
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):151-60. PubMed ID: 4216249
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fractionation of S. typhi Vi-antigen preparations by the gel filtration method on sephadex G-200].
    Samsonova VS; Kholchev NV; Alliluev AP; Shandalov BIa; Kliuikova TM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):3-7. PubMed ID: 4207095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complex experimental study on anti-Salmonella typhi vaccination. Protective property of human and rabbit serums for the mouse and chick embryo].
    Dimache G; Vladoianu IR; Dimache V; Popesco P
    Ann Inst Pasteur (Paris); 1971 Jun; 120(6):817-29. PubMed ID: 5557381
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Wong KH; Feeley JC; Northrup RS; Forlines ME
    Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the serum immunoglobulins to the somatic antigen of S. typhosa in an infant following intrauterine immunization.
    Bellanti JA; Jackson AL
    J Pediatr; 1967 Dec; 71(6):783-9. PubMed ID: 4168441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.